Stay updated on Sasanlimab in Advanced Malignancies Clinical Trial
Sign up to get notified when there's something new on the Sasanlimab in Advanced Malignancies Clinical Trial page.

Latest updates to the Sasanlimab in Advanced Malignancies Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; this appears to be a minor system/UI update with no changes to study content, eligibility, or primary data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision: v3.4.1 is displayed, replacing v3.4.0; the page content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check33 days agoChange DetectedUI changes include a glossary toggle (Show glossary / Hide glossary) and minor metadata updates such as capitalization in labels like 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', with the revision noted as v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check41 days agoChange DetectedMinor revision update from v3.3.3 to v3.3.4; no substantive changes to study content, eligibility criteria, or results were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check69 days agoChange DetectedLocations section updated: new site entries added (Beijing Municipality, Chongqing Municipality, Jiangsu, Shanghai Municipality, Tokyo, Pesochny, Sankt-Peterburg, Stavropol Kray, Yaroslavl Oblast, Gyeonggi-do, Kyiv Oblast, Kyivska Oblast, Sumska Oblast) and several previously listed locations removed. Page revision updated to v3.3.3.SummaryDifference1%

- Check90 days agoChange DetectedMinor textual updates: PubMed publications are automatically filled from PubMed, and the revision history now notes v3.3.2 (replacing v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Sasanlimab in Advanced Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sasanlimab in Advanced Malignancies Clinical Trial page.